CN1098201A - One-hole Assay of Multiple Immune Markers of Hepatitis Virus - Google Patents
One-hole Assay of Multiple Immune Markers of Hepatitis Virus Download PDFInfo
- Publication number
- CN1098201A CN1098201A CN 93112309 CN93112309A CN1098201A CN 1098201 A CN1098201 A CN 1098201A CN 93112309 CN93112309 CN 93112309 CN 93112309 A CN93112309 A CN 93112309A CN 1098201 A CN1098201 A CN 1098201A
- Authority
- CN
- China
- Prior art keywords
- hrp
- macropore
- hepatitis virus
- hbs
- hbe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 36
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 36
- 241000700605 Viruses Species 0.000 title claims abstract description 33
- 238000003556 assay Methods 0.000 title claims description 11
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 239000000427 antigen Substances 0.000 claims abstract description 31
- 102000036639 antigens Human genes 0.000 claims abstract description 31
- 108091007433 antigens Proteins 0.000 claims abstract description 31
- 239000003550 marker Substances 0.000 claims abstract description 23
- 210000002966 serum Anatomy 0.000 claims abstract description 21
- 239000000758 substrate Substances 0.000 claims abstract description 6
- 101710142246 External core antigen Proteins 0.000 claims abstract 7
- 102000004190 Enzymes Human genes 0.000 claims description 60
- 108090000790 Enzymes Proteins 0.000 claims description 60
- 238000002372 labelling Methods 0.000 claims description 15
- 238000000926 separation method Methods 0.000 claims description 8
- 101710132601 Capsid protein Proteins 0.000 claims description 6
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000001900 immune effect Effects 0.000 claims 13
- 238000006911 enzymatic reaction Methods 0.000 claims 8
- 230000036039 immunity Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 11
- 241000700721 Hepatitis B virus Species 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 208000002672 hepatitis B Diseases 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 241000709721 Hepatovirus A Species 0.000 description 4
- 239000011259 mixed solution Substances 0.000 description 4
- 241000711549 Hepacivirus C Species 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 101710120037 Toxin CcdB Proteins 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
最常用的肝炎病毒免疫标志有HBsAg,抗 HBs,HBeAg,抗HBe,抗HAV,抗HCV,实验方法 为反应板孔的酶免疫法,现用的检测方法每孔只能显 示离体的(抽取的)血清中的一个肝炎病毒免疫标 志。本发明将反应板孔按实际需要分为2—5个小 孔,分别包被有不同的抗原和抗体,在加待检血清后, 同时加入相应的酶标记混合液,经37℃—43℃中反 应1小时,用TBM底物系统显色,可以通过一次操 作,在同一孔中同时测定两个以上肝炎病毒免疫标 志,比常规操作方法功效提高1—4倍。
The most commonly used hepatitis virus immune markers are HBsAg, anti-HBs, HBeAg, anti-HBe, anti-HAV, and anti-HCV. A hepatitis virus immune marker in serum. In the present invention, the wells of the reaction plate are divided into 2-5 small wells according to the actual needs, which are respectively coated with different antigens and antibodies. React in medium for 1 hour, and use TBM substrate system to develop color. Through one operation, more than two immune markers of hepatitis virus can be measured in the same well at the same time, which is 1-4 times more effective than the conventional operation method.
Description
本发明属于肝炎病毒免疫标志的酶免疫方法。The invention belongs to the enzyme immune method of hepatitis virus immune marker.
肝炎病毒的免疫标志主要有抗HAV(抗Hepatitis A virus,甲肝病毒抗体)、HBsAg(Hepatitis B surface Antigen,乙肝病毒表面抗原)、HBeAg(Hepatitis B e Antigen,乙肝病毒e抗原)、抗HBc(抗Hepatitis B core,乙肝病毒表面抗体)、抗HBe(抗Hepatitis B e,乙肝病毒e抗体)、抗HCV(抗Hepatitis C virus,丙肝病毒抗体)。这些病毒免疫标志经常采用酶联免疫吸附试验检查。但这种酶免疫方法要使用多孔的酶标反应板,每孔只能检查一个免疫标志,使用上很不方便。The immune markers of hepatitis virus mainly include anti-HAV (anti-Hepatitis A virus, hepatitis A virus antibody), HBsAg (Hepatitis B surface Antigen, hepatitis B virus surface antigen), HBeAg (Hepatitis B e Antigen, hepatitis B virus e antigen), anti-HBc (anti-HBc Hepatitis B core, hepatitis B virus surface antibody), anti-HBe (anti-Hepatitis B e, hepatitis B virus e antibody), anti-HCV (anti-Hepatitis C virus, hepatitis C virus antibody). These viral immune markers are often checked using ELISA. However, this enzyme immunoassay method needs to use a multi-hole enzyme-labeled reaction plate, and only one immune marker can be checked in each well, which is very inconvenient to use.
本发明的目的在于提供一种在酶标反应板一孔中通过一次操作,即能同时显示两项或两项以上肝炎病毒免疫标志的快速简便的测定方法。The purpose of the present invention is to provide a fast and simple assay method that can simultaneously display two or more hepatitis virus immune markers through one operation in one well of an enzyme-labeled reaction plate.
本发明的另一目的在于提供一种相应于上述肝炎病毒免疫标志测定方法的酶标反应板。Another object of the present invention is to provide an enzyme-labeled reaction plate corresponding to the above-mentioned hepatitis virus immune marker assay method.
通常的酶免疫吸附试验法测定肝炎的免疫标志主要应用夹心法和竞争法两种,检查乙肝病毒表面抗原(HBsAg),乙肝病毒表面抗体(抗HBs)和乙肝病毒e抗原(HBeAg)应用的是夹心法,存在免疫标志时显色;反之,不显色。乙肝病毒e抗体(抗HBe)和乙肝病毒核心抗体(抗HBc)采用的是竞争法,待检抗体阳性时不显色,否则显色。这种酶免疫法先要将抗原或抗体包被(即吸附)在酶标反应板孔中,待检血清中存在相对应的抗体或抗原时,就通过抗原、抗体间的反应结合到反应板上。然后同时加入的辣根过氧化物酶(Horseradish peroxidase简写为HRP)标记的抗原或抗体,通过待检血清中的抗体或抗原结合到酶标反应板上(夹心法),或受血清中抗体的竞争不能结合到板上(竞争法),再加酶的底物溶液后,酶催化底物而显色,从而确定待检血清中是否存在抗原或抗体。由于抗原与相应抗体会起反应,酶标HBsAg和酶标抗HBs不能处于同一溶液中。因此,反应板上的同一个孔中只能测定一个免疫标志,各种酶标物需要分隔存放。但经发明人研究证实,若将酶标板的每个孔分隔为2-5个小孔,各小孔中分别包被不同的抗原或抗体,则它们之间不会相互干扰影响,待检血清中的各种肝炎病毒免疫标志会分别与小孔中包被的抗原或抗体相结合。并且,同一溶液中的酶标记物:抗HBs-HRP,抗HBe-HRP和抗HBc-HRP不会相互反应。这种酶标记物混合液加入大孔中,又可各自与小孔中的抗原、抗体相结合。因此,可以通过加一次血样和一次酶结合物,在一个大孔中能同时显示肝炎病毒的多项免疫标志。The usual enzyme immunosorbent assay method to determine the immune markers of hepatitis mainly uses the sandwich method and the competition method. The application of the hepatitis B virus surface antigen (HBsAg), hepatitis B virus surface antibody (anti-HBs) and hepatitis B virus e antigen (HBeAg) is Sandwich method, when there are immune markers, it develops color; otherwise, it does not develop color. Hepatitis B virus e antibody (anti-HBe) and hepatitis B virus core antibody (anti-HBc) adopt a competition method, and no color will be developed when the antibody to be tested is positive, otherwise color will be developed. In this enzyme immunoassay, the antigen or antibody must first be coated (that is, adsorbed) in the well of the enzyme-labeled reaction plate. When the corresponding antibody or antigen exists in the serum to be tested, it will bind to the reaction plate through the reaction between the antigen and the antibody. superior. Then the horseradish peroxidase (Horseradish peroxidase abbreviated as HRP)-labeled antigen or antibody added at the same time binds to the enzyme-labeled reaction plate through the antibody or antigen in the serum to be tested (sandwich method), or is stimulated by the antibody in the serum. The competition cannot be bound to the plate (competition method), and after adding the enzyme substrate solution, the enzyme catalyzes the substrate to develop color, so as to determine whether there is an antigen or antibody in the serum to be tested. Because the antigen will react with the corresponding antibody, enzyme-labeled HBsAg and enzyme-labeled anti-HBs cannot be in the same solution. Therefore, only one immune marker can be measured in the same well on the reaction plate, and various enzyme markers need to be stored separately. However, research by the inventors has confirmed that if each hole of the microtiter plate is divided into 2-5 small holes, and each small hole is coated with different antigens or antibodies, then they will not interfere with each other. Various hepatitis virus immune markers in the serum will combine with the antigens or antibodies coated in the small wells respectively. Also, the enzyme labels in the same solution: anti-HBs-HRP, anti-HBe-HRP and anti-HBc-HRP will not react with each other. This enzyme-labeled mixture is added into the large well, and can be combined with the antigen and antibody in the small well respectively. Therefore, by adding one blood sample and one enzyme conjugate, multiple immune markers of hepatitis virus can be displayed simultaneously in one large well.
本发明将酶标反应板设计成下述形状(如附图1-7所示),一般长度为110-140mm,宽度为45-70mm,厚度为10-15mm,可安排4×10个大孔。实际上其大小及大孔数不受限制。关键是对大孔的设计。大孔(1)直径一般为6-12mm,孔深10-14mm,将每个大孔分隔为2-5个小孔,每个小孔(2)底面积为5-15mm2,分隔层(3)高度为5-8mm,厚度为0.7-1.1mm。图1为酶标反应板的结构示意图。图2、图3为将大孔分隔为2个小孔的示意图。图4、图5为将大孔分隔为3个小孔的一种结构示意图。图6、图7为将大孔分隔为5个小孔的一种结构示意图。本发明提出的测定肝炎病毒免疫标志的步骤如下:在每个大孔的2-5个分隔小孔中分别包被不同的肝炎病毒免疫标志,即分别包被不同的抗原或抗体,包被物浓度为0.5-20ug/ml,反应条件一般为39℃±3℃,2-5小时,或者在6℃±2℃,15-48小时。试验时,对每个大孔中分别加待检血清,一般为0.05-0.2ml即可,同时各大孔中加入相应于小孔中包被的抗原或抗体的酶标记物的混合液0.1-0.3ml,在39℃±3℃中反应30-60分钟。然后去除孔中液体。并用洗涤液洗去未结合物,加上四甲基联苯胺(TMB)底物系统。一般每小孔中45-55ul,10分钟左右后即在一个大孔中显示待检血清各项免疫标志的阴性或阳性结果。In the present invention, the enzyme-labeled reaction plate is designed into the following shape (as shown in Figure 1-7), the general length is 110-140mm, the width is 45-70mm, the thickness is 10-15mm, and 4×10 large holes can be arranged . Its size and number of macropores are practically unlimited. The key is the design of the large holes. The diameter of the large hole (1) is generally 6-12mm, and the hole depth is 10-14mm. Each large hole is divided into 2-5 small holes. The bottom area of each small hole (2) is 5-15mm 2 , and the separation layer ( 3) The height is 5-8mm and the thickness is 0.7-1.1mm. Figure 1 is a schematic diagram of the structure of an enzyme-labeled reaction plate. Figure 2 and Figure 3 are schematic diagrams of dividing a large hole into two small holes. Fig. 4 and Fig. 5 are schematic diagrams of a structure in which a large hole is divided into three small holes. Fig. 6 and Fig. 7 are schematic diagrams of a structure in which a large hole is divided into five small holes. The steps for measuring the immune markers of hepatitis virus proposed by the present invention are as follows: 2-5 separate small holes of each large hole are coated with different immune markers of hepatitis virus respectively, that is, different antigens or antibodies are coated respectively, and the coating material The concentration is 0.5-20ug/ml, and the reaction conditions are generally 39°C±3°C for 2-5 hours, or 6°C±2°C for 15-48 hours. During the test, the serum to be tested is added to each large well, generally 0.05-0.2ml, and at the same time, 0.1-0.1ml of the enzyme-labeled mixture corresponding to the antigen or antibody coated in the small well is added to each large well. 0.3ml, react at 39℃±3℃ for 30-60 minutes. The liquid in the pores is then removed. And wash off unbound material with washing solution, plus tetramethylbenzidine (TMB) substrate system. Generally, there is 45-55ul in each small hole, and after about 10 minutes, the negative or positive results of various immune markers in the serum to be tested will be displayed in a large hole.
在本发明提出的方法中,只要在酶标反应板的大孔的分隔小孔中任意选定包被物,并加入相对应的酶标记物的混合液,可以测定肝炎病毒免疫标志任意组合成的两项以上的免疫标志。下面是各种常用组合的举例:In the method proposed by the present invention, as long as the coating is arbitrarily selected in the partitioned small wells of the large holes of the enzyme-labeled reaction plate, and the corresponding mixed solution of enzyme markers is added, any combination of hepatitis virus immune markers can be determined. Two or more of the immune markers. The following are examples of various commonly used combinations:
如果在酶标反应板的一个大孔中的分隔小孔中分别包被抗HBs、抗HBe、HBcAg,则在酶标物反应步骤中加入相应的抗HBs-HRP、抗HBe-HRP、抗HBc-HRP酶标记物混合液,可以测定乙型肝炎表面抗原(HBsAg)、乙型肝炎e抗原(HBeAg)和乙型肝炎核心抗体(抗HBc)三个免疫标志。If anti-HBs, anti-HBe, and HBcAg are respectively coated in separate small wells in a large well of the enzyme labeling reaction plate, add the corresponding anti-HBs-HRP, anti-HBe-HRP, and anti-HBc in the enzyme labeling reaction step. -HRP enzyme marker mixture, which can measure the three immune markers of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg) and hepatitis B core antibody (anti-HBc).
如果在酶标反应板的一个大孔的分隔小孔中分别包被HBsAg和HBeAg,则在酶标记物反应步骤中加入相应的HBsAg-HRP和抗HBe-HRP酶标记物混合液,可以测定乙型肝炎表面抗体(抗HBs)和乙型肝炎e抗体(抗HBe)两个肝炎免疫标志。If HBsAg and HBeAg are respectively coated in the separate wells of a large hole in the enzyme labeling reaction plate, then the corresponding HBsAg-HRP and anti-HBe-HRP enzyme labeling mixture is added in the enzyme labeling reaction step, and B can be determined. Hepatitis surface antibody (anti-HBs) and hepatitis B e antibody (anti-HBe) are two immune signs of hepatitis.
如果在酶标反应板的一个大孔的分隔小孔中分别包被抗HBs、HBsAg、抗HBe、HBeAg和HBcAg,则在酶标物反应步骤中加入相应的抗HBs-HRP、抗HBe-HRP和抗HBc-HRP酶标记物混合液,可以测定HBsAg、HBeAg、抗HBc、抗HBs和抗HBe五项免疫标志。If anti-HBs, HBsAg, anti-HBe, HBeAg, and HBcAg are respectively coated in a large well of the enzyme labeling reaction plate, add the corresponding anti-HBs-HRP, anti-HBe-HRP in the enzyme labeling reaction step And anti-HBc-HRP enzyme marker mixture, can measure HBsAg, HBeAg, anti-HBc, anti-HBs and anti-HBe five immune markers.
如果在酶标反应板的一个大孔的分隔小孔中分别包被抗HBs和HCV抗原,则在酶标物反应步骤中加入相应的抗HBs-HRP和抗人IgG-HRP(抗人免疫球蛋白G酶标物)或HCV-HRP(丙肝病毒抗原酶标物)酶标记物混合液,可以测定乙型肝炎病毒表面抗原(HBsAg)和丙型肝炎病毒抗体(抗HCV)。If the anti-HBs and HCV antigens are respectively coated in a large well of the enzyme-labeled reaction plate, add the corresponding anti-HBs-HRP and anti-human IgG-HRP (anti-human immunoglobulin) in the enzyme-labeled reaction step. Protein G enzyme marker) or HCV-HRP (hepatitis C virus antigen enzyme marker) enzyme marker mixture, can detect hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibody (anti-HCV).
如果在酶标反应板的一个大孔的分隔小孔中分别包被抗HBs,抗HBe和HCV抗原,则在酶标物反应步骤中加入相应的抗HBs-HRP、抗HBe-HRP和抗人IgG-HRP(或HCV-HRP)的酶标记物混合液,可以测定HBsAg、HBeAg和抗HCV。If anti-HBs, anti-HBe and HCV antigens are respectively coated in a large well of the enzyme-labeled reaction plate, the corresponding anti-HBs-HRP, anti-HBe-HRP and anti-human IgG-HRP (or HCV-HRP) enzyme marker mixture can detect HBsAg, HBeAg and anti-HCV.
如果在酶标反应板的一个大孔的分隔小孔中分别包被HBs,抗HBe和HAV抗原,则在酶标物反应步骤中加入相应的抗HBs-HRP、抗HBe-HRP和抗u-HRP(抗人u链酶标物)酶标记物混合液,可以测定HBsAg、HBeAg及甲型肝炎病毒抗体(抗HAV)(IgM)。If HBs, anti-HBe and HAV antigens are respectively coated in the separate wells of a large well of the enzyme labeling reaction plate, the corresponding anti-HBs-HRP, anti-HBe-HRP and anti-u- HRP (anti-human u-chain enzyme marker) enzyme-labeled mixture can detect HBsAg, HBeAg and hepatitis A virus antibody (anti-HAV) (IgM).
本发明与通常的测定方法相比,工作效率提高2-4倍,血清用量也为减少。按通常方法,乙肝病毒的五项免疫标志的测定,每份血清需同时加5次,在5个孔中反应,一次血清用量为0.5ml,酶标记物也加5次,分别在各个孔中反应。本发明可以将5个免疫标志在1个(或2个)孔中测定,加血清和酶标记物各1次(或2次)可同时显示5个乙肝免疫标志的结果。对其它肝炎病毒免疫标志的混合检测,工作效率同样明显提高,血清用量相应减少。Compared with the usual measuring method, the present invention improves the work efficiency by 2-4 times and reduces the amount of serum used. According to the usual method, for the determination of the five immune markers of hepatitis B virus, each serum needs to be added 5 times at the same time, and reacted in 5 wells. reaction. In the present invention, five immune markers can be measured in one (or two) wells, and the results of five hepatitis B immune markers can be displayed simultaneously by adding serum and enzyme markers once (or twice). For the mixed detection of other hepatitis virus immune markers, the work efficiency is also significantly improved, and the amount of serum is correspondingly reduced.
图1为酶标反应板(条)的结构示意图Figure 1 is a schematic diagram of the structure of the enzyme-labeled reaction plate (strip)
图2为酶标反应板(条)上大孔分隔成2个小孔的结构侧视图。Figure 2 is a side view of the structure of a large well divided into two small wells on an enzyme-labeled reaction plate (strip).
图3为酶标反应板(条)上大孔分隔成2个小孔的结构俯视图。Figure 3 is a top view of the structure of a large well divided into two small wells on an enzyme-labeled reaction plate (strip).
图4为酶标反应板(条)上大孔分隔成3个小孔的结构侧视图。Figure 4 is a side view of the structure of a large well divided into three small wells on an enzyme-labeled reaction plate (strip).
图5为酶标反应板(条)上大孔分隔成3个小孔的结构俯视图。Figure 5 is a top view of the structure of a large well divided into three small wells on an enzyme-labeled reaction plate (strip).
图6为酶标反应板(条)上大孔分隔成5个小孔的结构侧视图。Figure 6 is a side view of the structure of the large wells divided into 5 small wells on the enzyme-labeled reaction plate (strip).
图7为酶标反应板(条)上大孔分隔成5个小孔的结构俯视图。Figure 7 is a top view of the structure of the large wells divided into 5 small wells on the enzyme-labeled reaction plate (strip).
实施例1Example 1
在1孔3间隔小孔中同时包被抗HBe,抗HBs和HBcAg,加入含HBeAg、HBsAg和抗HBc同时阳性的血清0.2ml,同时加抗HBs-HRP、抗HBe-HRP和抗HBc-HRP混合液0.1ml,37℃温箱中反应1小时,加TMB底物液后孔中3间隔小孔中均呈现阳性结果。Coat anti-HBe, anti-HBs and HBcAg in 1 well with 3 intervals, add 0.2ml of serum containing HBeAg, HBsAg and anti-HBc positive at the same time, add anti-HBs-HRP, anti-HBe-HRP and anti-HBc-HRP at the same time The mixed solution was 0.1ml, reacted in a 37°C incubator for 1 hour, and after adding TMB substrate solution, all three interval small wells in the wells showed positive results.
实施例2Example 2
在1孔2间隔小孔中,同时包被HBsAg和HBeAg,加入含抗HBs和抗HBe同时阳性的血清(或抗HBs阳性血清中加已知的抗HBe阳性血清)0.2ml,同时加HBsAg-HRP和抗HBe-HRP混合液0.1ml,37℃温箱中反应1小时,加TMB底物液后孔中2间隔区,测抗HBs的小孔显色,而测抗HBe的小孔为无色,即两个孔均显示阳性结果。In 1 well with 2 spaced wells, coat HBsAg and HBeAg at the same time, add 0.2ml of anti-HBs and anti-HBe positive serum (or add known anti-HBe positive serum to anti-HBs positive serum), and add HBsAg- HRP and anti-HBe-HRP mixed solution 0.1ml, react in a 37°C incubator for 1 hour, after adding TMB substrate solution, there are 2 spacers in the well, the well for measuring anti-HBs develops color, while the well for measuring anti-HBe shows no color color, that is, both wells show positive results.
实施例3Example 3
在酶标反应板各小孔中分别包被抗HBs,HBsAg,抗HBe,HBeAg和HBcAg加HBsAg,HBeAg,抗HBc阳性血清0.2ml,37℃中反应1小时,加TMB底物系统,结果上述各包被小孔中分别为显色、显色、显色、显色和无色,即检测结果为HBsAg、HBeAg、抗HBc阳性,而抗HBs和抗HBe为阴性。在上述包被孔中加抗HBs和抗HBe阳性血清,同时加上述酶标记物混合液后,底物系统显色次序为无色、无色、无色、无色和显色,即检测结果为抗HBs和抗HBe阳性。Coat anti-HBs, HBsAg, anti-HBe, HBeAg and HBcAg plus HBsAg, HBeAg, anti-HBc positive serum 0.2ml in each well of the enzyme-labeled reaction plate, react at 37°C for 1 hour, add TMB substrate system, the result is as above In each of the coated wells, there are color development, color development, color development, color development and colorless respectively, that is, the test results are positive for HBsAg, HBeAg and anti-HBc, but negative for anti-HBs and anti-HBe. After adding anti-HBs and anti-HBe positive sera to the above-mentioned coated wells, and adding the above-mentioned enzyme marker mixture at the same time, the color development sequence of the substrate system is colorless, colorless, colorless, colorless and color, that is, the detection result Positive for anti-HBs and anti-HBe.
实施例4Example 4
在酶标反应板各小孔中分别包被抗HBs和HCV抗原,加HBsAg和抗HCV的阳性血清0.1-0.2ml。同时加抗HBs-HRP和HCV-HRP混合液0.1-0.2ml,37℃中反应1小时,加TMB底物后2个小孔中分别显色,即检测结果为HBsAg阳性和抗HCV阳性。Coat anti-HBs and HCV antigens in each well of the enzyme-labeled reaction plate, and add 0.1-0.2 ml of HBsAg and anti-HCV positive serum. Simultaneously add 0.1-0.2ml of anti-HBs-HRP and HCV-HRP mixture, react at 37°C for 1 hour, after adding TMB substrate, the two small wells develop color respectively, that is, the test results are positive for HBsAg and positive for anti-HCV.
实施例5Example 5
在酶标反应板各小孔中分别包被抗HBs和HAV抗原,加HBsAg和抗HAV阳性血清0.1-0.2ml,同时加抗HBs-HRP和抗人u-HRP混合液0.1-0.2ml,37℃反应1小时后加TMB底物液,2个小孔中均显色,示HBsAg和抗HAV均为阳性。Coat anti-HBs and HAV antigens in each well of the enzyme-labeled reaction plate, add HBsAg and anti-HAV positive serum 0.1-0.2ml, add anti-HBs-HRP and anti-human u-HRP mixed solution 0.1-0.2ml at the same time, 37 After reacting at ℃ for 1 hour, TMB substrate solution was added, and the two small wells developed color, showing that both HBsAg and anti-HAV were positive.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 93112309 CN1098201A (en) | 1993-01-12 | 1993-01-12 | One-hole Assay of Multiple Immune Markers of Hepatitis Virus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 93112309 CN1098201A (en) | 1993-01-12 | 1993-01-12 | One-hole Assay of Multiple Immune Markers of Hepatitis Virus |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1098201A true CN1098201A (en) | 1995-02-01 |
Family
ID=4989932
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 93112309 Pending CN1098201A (en) | 1993-01-12 | 1993-01-12 | One-hole Assay of Multiple Immune Markers of Hepatitis Virus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1098201A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003104808A1 (en) * | 2002-06-06 | 2003-12-18 | Chengdu Kuachang Science & Technology Co., Ltd. | New probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate |
EP1373467A4 (en) * | 2001-03-28 | 2007-06-06 | Genetech Biotechnology Shangai | Device and method for detection of multiple analytes |
CN101750493A (en) * | 2008-12-17 | 2010-06-23 | 北京科美东雅生物技术有限公司 | Enzymatic chemiluminescence immunoassay qualitative diagnostic reagent kit for simultaneously testing communicable disease projects |
CN109557149A (en) * | 2019-01-14 | 2019-04-02 | 大连大学 | Digital microcurrent-controlled chip and pathogen immunologic detection method based on pcb board |
-
1993
- 1993-01-12 CN CN 93112309 patent/CN1098201A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1373467A4 (en) * | 2001-03-28 | 2007-06-06 | Genetech Biotechnology Shangai | Device and method for detection of multiple analytes |
WO2003104808A1 (en) * | 2002-06-06 | 2003-12-18 | Chengdu Kuachang Science & Technology Co., Ltd. | New probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate |
CN1333254C (en) * | 2002-06-06 | 2007-08-22 | 成都夸常科技有限公司 | Novel probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate |
CN101750493A (en) * | 2008-12-17 | 2010-06-23 | 北京科美东雅生物技术有限公司 | Enzymatic chemiluminescence immunoassay qualitative diagnostic reagent kit for simultaneously testing communicable disease projects |
CN109557149A (en) * | 2019-01-14 | 2019-04-02 | 大连大学 | Digital microcurrent-controlled chip and pathogen immunologic detection method based on pcb board |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5705330A (en) | Chemiluminescent immunoassay for antibody detection | |
EP0160900B1 (en) | Immunoassay for the detection of ligands | |
CA2318459C (en) | Neutralization of polycations in a chromatographic device for whole blood use | |
FI80345B (en) | VISUALISERINGSFOERFARANDE FOER DIREKT ELLER INDIREKT DETEKTERING AV ETT AGGLOMERAT BILDAT AV ETT SPECIFIKT BINDANDE AEMNE OCH EN MOTSVARANDE ACCEPTORSUBSTANS VID BLOT OVERLAY-BESTAEMNINGAR OCH I DESSABESTAEMANAR | |
EP0138826B1 (en) | Detection of human chorionic gonadotropin | |
AU645835B2 (en) | Simultaneous assay for detecting one or more analytes | |
JPS59208463A (en) | Solid-phase immunoassay method containing luminescent mark | |
US5206136A (en) | Rapid membrane affinity concentration assays | |
US5792606A (en) | Nucleic acid hybridization based assay for determining a substance of interest | |
CN1098201A (en) | One-hole Assay of Multiple Immune Markers of Hepatitis Virus | |
CA2097545C (en) | Process for the immunochemical determination of an analyte | |
AU650503B2 (en) | Amplified heterogeneous chemiluminescent immunoassay | |
AU659754B2 (en) | Chromatographic antigen sandwich test for detection of specific antibody and device therefor | |
US5437981A (en) | Method for the immunological determination of ligands | |
JP2002525607A5 (en) | ||
JP2657377B2 (en) | Immunoassay for antibodies against HTLV-III | |
KR890007076A (en) | Immunoassay Using Antigens Produced in Heterologous Organisms | |
CN1131432C (en) | Method and reagent for directy detecting serum hepatitis B virus core antigen | |
KR930702507A (en) | Monoclonal Antibodies to Hepatitis C Virus and Methods of Use thereof | |
US4701421A (en) | Determination of protecting anti-HBV immunoglobulins | |
US5783455A (en) | Regenerable solid phase for carrying out specific binding reactions | |
CN2148332Y (en) | Reaction sheet (strap) for examining multiple immune marks of hepatitis by one hole method | |
US4701410A (en) | Method for the immunochemical determination of hepatitis B core antigens | |
Miyai | Classification of immunoassay | |
Glad | Immunocapillarymigration: Use of fluorescein-and enzyme-labeled antibodies to quantify C-reactive protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C01 | Deemed withdrawal of patent application (patent law 1993) | ||
WD01 | Invention patent application deemed withdrawn after publication |